MNMD MEXC RealStocks
Own real MNMD shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 07:18:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Mind Medicine (MindMed) Inc. (MNMD) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Mind Medicine (MindMed) Inc. (MNMD) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, MNMD traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, Mind Medicine (MindMed) Inc. (MNMD) moved from $13.70 to $15.02, representing a gain of 9.64% ($1.32).
The stock traded between $12.88 and $15.29 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 2.47 million shares, up versus the previous seven-day period, indicating higher trading activity.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 74 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mind Medicine (MindMed) Inc. (MNMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MNMD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between MNMD shares and USD.
MNMD Shares to USD
1.00 MNMD shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.